Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is the 23rd Most Popular Stock Among 752 Hedge Funds

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and successful investors’ positions as of the end of the third quarter. You can find articles about an individual hedge fund’s trades on numerous financial news websites. However, in this article we will take a look at their collective moves over the last 4 years and analyze what the smart money thinks of Allergan plc (NYSE:AGN) based on that data. We also compare Allergan’s hedge fund sentiment against its peers like The Charles Schwab Corp (NYSE:SCHW), Raytheon Company (NYSE:RTN), Target Corporation (NYSE:TGT), and General Motors Company (NYSE:GM).

Allergan plc (NYSE:AGN) has experienced an increase in hedge fund interest of late. Our calculations also showed that AGN ranked 23rd among the 30 most popular stocks among hedge funds.

In the financial world there are a large number of tools investors have at their disposal to grade stocks. A pair of the most under-the-radar tools are hedge fund and insider trading indicators. We have shown that, historically, those who follow the top picks of the best fund managers can outperform the broader indices by a solid amount. Insider Monkey’s flagship best performing hedge funds strategy returned 91% since May 2014 and outperformed the Russell 2000 ETFs by nearly 40 percentage points. Our short strategy outperformed the S&P 500 short ETFs by 20 percentage points annually (see the details here). That’s why we believe hedge fund sentiment is a useful indicator that investors should pay attention to.

Third Point 2014 Q3 Investor Letter

Dan Loeb of Third Point

Unlike the largest US hedge funds that are convinced Dow will soar past 40,000 or the world’s most bearish hedge fund that’s more convinced than ever that a crash is coming, our long-short investment strategy doesn’t rely on bull or bear markets to deliver double digit returns. We only rely on the best performing hedge funds‘ buy/sell signals. We’re going to review the latest hedge fund action encompassing Allergan plc (NYSE:AGN).

How have hedgies been trading Allergan plc (NYSE:AGN)?

At Q3’s end, a total of 81 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 1% from the second quarter of 2019. Below, you can check out the change in hedge fund sentiment towards AGN over the last 17 quarters. So, let’s see which hedge funds were among the top holders of the stock and which hedge funds were making big moves.


The largest stake in Allergan plc (NYSE:AGN) was held by Adage Capital Management, which reported holding $1072.3 million worth of stock at the end of September. It was followed by Renaissance Technologies with a $618.3 million position. Other investors bullish on the company included Third Point, Paulson & Co, and Millennium Management. In terms of the portfolio weights assigned to each position MFN Partners allocated the biggest weight to Allergan plc (NYSE:AGN), around 35.22% of its portfolio. Sarissa Capital Management is also relatively very bullish on the stock, earmarking 21.99 percent of its 13F equity portfolio to AGN.

As one would reasonably expect, some big names were breaking ground themselves. Third Point, managed by Dan Loeb, established the most valuable position in Allergan plc (NYSE:AGN). Third Point had $605.8 million invested in the company at the end of the quarter. Scott Ferguson’s Sachem Head Capital also initiated a $212.9 million position during the quarter. The other funds with new positions in the stock are James Dinan’s York Capital Management, Isaac Corre’s Governors Lane, and John Orrico’s Water Island Capital.

Let’s check out hedge fund activity in other stocks – not necessarily in the same industry as Allergan plc (NYSE:AGN) but similarly valued. We will take a look at The Charles Schwab Corp (NYSE:SCHW), Raytheon Company (NYSE:RTN), Target Corporation (NYSE:TGT), and General Motors Company (NYSE:GM). This group of stocks’ market values resemble AGN’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
SCHW 52 3125721 4
RTN 49 3254934 10
TGT 53 2073012 16
GM 68 6375993 19
Average 55.5 3707415 12.25

View table here if you experience formatting issues.

As you can see these stocks had an average of 55.5 hedge funds with bullish positions and the average amount invested in these stocks was $3707 million. That figure was $8207 million in AGN’s case. General Motors Company (NYSE:GM) is the most popular stock in this table. On the other hand Raytheon Company (NYSE:RTN) is the least popular one with only 49 bullish hedge fund positions. Compared to these stocks Allergan plc (NYSE:AGN) is more popular among hedge funds. Our calculations showed that top 20 most popular stocks among hedge funds returned 34.7% in 2019 through November 22nd and outperformed the S&P 500 ETF (SPY) by 8.5 percentage points. Hedge funds were also right about betting on AGN as the stock returned 9.7% during Q4 (through 11/22) and outperformed the market by an even larger margin. Hedge funds were clearly right about piling into this stock relative to other stocks with similar market capitalizations.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.